Latest Breaking News On - Venous thromboembolism - Page 2 : comparemela.com

Anticoagulants Market size to record USD 18.09 billion growth from 2023-2027, Advent of anticoagulant antidotes is one of the key market trends, Technavio

/PRNewswire/ The global anticoagulants market size is estimated to grow by USD 18.09 billion from 2023 to 2027, according to Technavio. The market is.

Study shows antipsychotic drugs increase health risks in dementia patients

Study found that antipsychotic drug use in dementia patients is linked to increased risks of stroke, heart failure, and other serious conditions.

Novel prophylactic anticoagulation scoring tool helps stratify patients following lower limb trauma

1. The 3-month symptomatic venous thromboembolism rate was 0.7% in patients with TRiP(cast) score < 7 and not receiving anticoagulation. 2. There was no significant difference between the control and intervention phases regarding secondary outcomes. Evidence Rating Level: 1 (Excellent) Study Rundown: Venous thromboembolism (VTE) is a well-recognized potential complication resulting from orthopedic trauma and

Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis

Vafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients

/PRNewswire/ CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved.